National Comprehensive Cancer Network

|
|
|
|
For Patients

About NCCN

Acute Myeloid Leukemia Panel

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Frederick R. Appelbaum, MD

None

None

None

None

10/28/2009

Steven E. Coutre, MD

Cephalon, Inc.;
Wyeth Pharmaceuticals

None

None

None

10/28/2009

Lloyd E. Damon, MD

None

None

Genentech, Inc.

None

10/28/2009

Harry P. Erba, MD, PhD

Cephalon, Inc.;
Eli Lilly and Company;
Exelixis Inc.;
Genzyme Corporation;
Kanisa Pharmaceuticals, Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Wyeth Pharmaceuticals;
Xanthus Pharmacueuticals, Inc.

Bristol-Myers Squibb Company;
Celgene Corporation;
Cephalon, Inc.;
Genzyme Corporation;
MGI PHARMA, INC.;
Novartis Pharmaceuticals Corporation;
Pharmion Corporation

None

National Cancer Institute

11/17/2009

James M. Foran, MD

Genzyme Corporation;
Ambit BioSciences;
Astex Therapeutics;
Seattle Genetics

Celgene Corporation;
Genzyme Corporation;
Astex Therapeutics

None

None

10/28/2009

Lauren Gallagher, PhD

None

None

None

None

8/28/2009

Salil Goorha, MD

None

None

None

None

9/28/2009

Kristina M Gregory, RN, MSN, OCN

None

None

None

None

8/21/2009

Rashmi Kumar, PhD

None

None

None

None

7/1/2009

Jeffrey Lancet, MD

None

Eisai Inc.;
Genzyme Corporation;
Novartis Pharmaceuticals Corporation

None

None

7/1/2009

Lori J. Maness, MD

None

None

None

None

10/28/2009

Guido Marcucci, MD

None

None

None

None

9/28/2009

Peter Maslak, MD

None

None

None

None

10/14/2009

Joan S McClure, MS

None

None

None

None

9/28/2009

Michael M. Millenson, MD, FACP

None

Celgene Corporation;
GlaxoSmithKline;
MGI PHARMA, INC.;
Pharmion Corporation

None

sanofi-aventis U.S.

10/28/2009

Joseph O. Moore, MD

Genentech, Inc.;
Novartis Pharmaceuticals Corporation

Amgen Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

10/28/2009

Margaret R. O'Donnell, MD

Eisai Inc.

Celgene Corporation;
Eisai Inc.;
Genzyme Corporation

None

None

11/16/2009

Farhad Ravandi, MD

Bayer HealthCare;
Cephalon, Inc.;
Eisai Inc.

Bayer HealthCare;
Cephalon, Inc.;
Eisai Inc.;
Genzyme Corporation;
Novartis Pharmaceuticals Corporation

None

None

10/28/2009

Paul J. Shami, MD

Genzyme Corporation

Novartis Pharmaceuticals Corporation

JSK Therapeutics Inc.

None

10/28/2009

B. Douglas Smith, MD

Bayer HealthCare;
Cephalon, Inc.;
Novartis Pharmaceuticals Corporation

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

10/28/2009

Richard M. Stone, MD

Bristol-Myers Squibb Company;
Celgene Corporation;
Novartis Pharmaceuticals Corporation

Celgene Corporation;
Eisai Inc.;
Genzyme Corporation;
ImClone Systems Incorporated;
Merck & Co., Inc.

None

None

10/28/2009

Stephen A. Strickland, MD

GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Cyclacel Pharmaceuticals;
Sunesis Pharmaceuticals, Inc.

Genzyme Corporation

None

None

10/29/2009

Martin S. Tallman, MD

None

Genzyme Corporation

None

None

10/28/2009

Eunice S. Wang, MD

None

None

None

None

10/28/2009

 

NCCN Website Supporters